T cells and reactive oxygen species by Aleksey V. Belikov et al.
REVIEW Open Access
T cells and reactive oxygen species
Aleksey V. Belikov1* , Burkhart Schraven2 and Luca Simeoni2
Abstract
Reactive oxygen species (ROS) have been long considered simply as harmful by-products of metabolism, which
damage cellular proteins, lipids, and nucleic acids. ROS are also known as a weapon of phagocytes, employed
against pathogens invading the host. However, during the last decade, an understanding has emerged that ROS
also have important roles as signaling messengers in a multitude of pathways, in all cells, tissues, and organs. T
lymphocytes are the key players of the adaptive immune response, which both coordinate other immune cells
and destroy malignant and virus-infected cells. ROS have been extensively implicated in T-cell hyporesponsiveness,
apoptosis, and activation. It has also become evident that the source, the kinetics, and the localization of ROS
production all influence cell responses. Thus, the characterization of the precise mechanisms by which ROS are
involved in the regulation of T-cell functions is important for our understanding of the immune response and for
the development of new therapeutic treatments against immune-mediated diseases. This review summarizes the
30-year-long history of research on ROS in T lymphocytes, with the emphasis on the physiological roles of ROS.
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Introduction to ROS
ROS are small short-lived oxygen-containing molecules
that are chemically highly reactive, a property that is
mainly due to their unpaired electrons (radicals). Super-
oxide (O2
•−), hydrogen peroxide (H2O2), hydroxyl radical
(OH•), hypochlorous acid (HOCl), lipid peroxides
(ROOH), singlet oxygen (1O2), and ozone (O3) are some
of the most common ROS [1]. The first two species are
the most important ROS involved in the regulation of
biological processes. O2
•− is usually the species from
which other ROS originate. Once produced, O2
•− either
rapidly reacts with surrounding molecules or dismutates
to H2O2, spontaneously or with the help of superoxide
dismutase (SOD) [2]. H2O2 is more stable, less reactive,
can diffuse in the microenvironment and even cross cell
membranes. H2O2 can either react with particular amino
acids, usually cysteines and methionines, or can be
converted to OH• (in the Fenton reaction), HOCl (by
myeloperoxidase), or H2O (with the help of catalase,
peroxidase, or peroxiredoxin) [3]. Both OH• and HOCl
are highly reactive and usually irreversibly damage
nearby molecules.
One of the major sources of ROS in the cell are
mitochondria [4, 5]. Mitochondria express the electron
transport chain (ETC.) complexes, which transfer
electrons from NADH and succinate, along a controlled
redox pathway, to the oxygen molecule (O2). Upon
receiving four electrons, O2 is reduced to H2O. However,
the ETC is not perfect, and occasionally O2 undergoes
one- or two-electron reduction to form O2
•− or H2O2,
respectively. Complexes I and III of the ETC are the
main sources of mitochondrial O2
•− [4, 5]. Multiple
metabolic enzymes, such as ERO-1, cytochromes P-450
and b5, lipoxygenases, cyclooxygenases, α-ketoglutarate-
and glycerol phosphate dehydrogenases, as well as
hydroxyacid-, urate-, xanthine-, monoamine-, diamine-,
polyamine-, and amino acid oxidases, are also producing
ROS as necessary intermediates or byproducts of their
reactions [6]. These enzymes can be found in mitochon-
dria, endoplasmic reticulum, peroxisomes, and cytosol.
There is also a large class of ROS producing enzymes
called NADPH oxidases (see below). Finally, there are
exogenous sources of ROS, including ultraviolet and
gamma radiation, smoke and other air pollutants, as well
as several drugs and chemicals. As ROS can damage
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proteins, lipids, and nucleic acids, the evolution has
created specialized antioxidant systems. There are anti-
oxidant enzymes, such as SODs, catalases, glutathione
peroxidases (GPXs), peroxiredoxins (PRXs), thioredoxins
(TRXs), glutaredoxins (GRXs), sulfiredoxins (SRXs),
thioredoxin reductases, glutathione reductases, and
methionine sulfoxide reductases [7], and also small
nonenzymatic antioxidant molecules, such as glutathi-
one, ascorbate, pyruvate, α-ketoglutarate, and oxal-
oacetate [8]. When the rate of ROS production in the
cell (or in the microenvironment) significantly exceeds
the rate of their neutralization by the antioxidant sys-
tems, the cell undergoes oxidative stress. Prolonged or
excessive oxidative stress can lead to the impairment of
cellular functions, cell death, senescence, or malignant
transformation [9–11].
Phagocytic cells produce ROS to kill engulfed bacteria
during the so-called respiratory burst [12]. In these cells,
ROS are produced by the phagocytic NADPH oxidase
(PHOX), an enzyme consisting of several subunits [13].
The catalytic subunit, called the PHOX glycoprotein of
91 kDa (gp91phox) or the NADPH oxidase 2 (NOX-2), is
expressed at either the plasma or phagosomal mem-
brane. PHOX includes also a variety of regulatory
subunits: membrane-anchored p22phox and cytoplasmic
p40phox, p47phox, and p67phox, as well as the RAC
GTPase. PHOX becomes functional upon the tightly
regulated assembly of this multisubunit complex. Inter-
estingly, six homologs of gp91phox (NOX-2) have been
identified in different tissues: NOX-1, NOX-3, NOX-4,
NOX-5, dual oxidase 1 (DUOX-1), and DUOX-2 [14,
15]. NOXs are usually activated upon the triggering of
cell receptors by their respective ligands, such as insulin,
angiotensin, PDGF, GM-CSF, TNF, chemokines that bind
G protein-coupled receptors, complement component
5a (C5a), lysophospholipids, and leukotriene B4, as well
as by cell adhesion and by phagocytosis [8]. Because of
the widespread yet differential expression of NOX and
DUOX isoforms across organelles, cell types, and organ-
isms, O2
•− and H2O2 can be considered as ubiquitous
signaling messengers. Indeed, during the last decade, it
has become evident that ROS are not just harmful
byproducts of metabolism and weapons of phagocytes
but are also crucial players in cellular signaling. ROS-
mediated signaling is involved in multiple processes,
such as cell growth [14, 15], stem cell renewal [16, 17],
tumorigenesis [8, 14, 17], cell death [14, 15], cell senes-
cence [15, 17], cell migration [16], oxygen sensing [15],
angiogenesis [15], circadian rhythm maintenance [16],
and immune responses [8, 15].
Among ROS, H2O2 acts as the major signaling
messenger and is excellently suited for this function [18].
In fact, it is stable enough, is able to cross cell membranes,
and is reacting preferentially with cysteine residues [3]. It
has to be noted that cysteine residues are amongst the
most conserved and least abundant protein residues [19],
which ensures high selectivity and specificity for oxida-
tion-mediated post-translational modifications. Moreover,
only specific cysteinyl thiols that, upon coordination with
neighboring amino acid side chains, can become thio-
late anions are able to react with H2O2 [20]. When
H2O2 oxidizes a cysteine thiolate anion (R-S
−), sulfenic
acid (R-SOH) is formed [21, 22]. This process, which is
referred to as sulfenylation, is reversed by GRXs and
TRXs [7, 20]. Thus, sulfenylation is believed to be akin
to phosphorylation or other post-translational mo-
difications. Sulfenylation may lead to further post-
translational modifications, such as glutathionylation,
disulfide bond formation, and sulfinilation [21, 22].
Most importantly, it can be involved in the regulation
of protein activity. In fact, sulfenylation can induce
changes in the protein conformation, thus leading to
the activation or inactivation of the catalytic center or
to other functional alterations of the protein. Multiple
protein classes have been shown to be regulated by
sulfenylation, including phosphatases and kinases,
transcription factors and histone deacetylases, antioxi-
dant enzymes and heat-shock proteins, proteases and
hydrolases, ion channels and pumps, adaptor mole-
cules and cytoskeleton components [8, 16, 17, 21–23].
It is believed that the NOX enzymes are the major
source of signaling ROS [24]. Nevertheless, it is likely
that ROS produced by the mitochondrial ETC or meta-
bolic enzymes are also involved in signaling processes
[25–28]. The levels of ROS that are involved in signal
transduction are much lower than the levels occurring
during respiratory burst or oxidative stress. Moreover,
due to the abundance of antioxidant systems in the cell,
ROS cannot travel long distances, and hence they
transmit signals only locally, in confined compartments
[29, 30]. In other words, the source and the corre-
sponding targets of signaling ROS usually have to be in
close proximity. ROS-mediated signaling can be addition-
ally regulated via controlled alterations in local levels and
activity of specific antioxidants [16, 23]. For example,
glutathione is a good scavenger for many ROS, such as
HOCl, but reacts too slowly with H2O2, the major
mediator of oxidative signaling. On the contrary, PRXs
have remarkably high reaction rates with H2O2, and their
activity is tightly regulated by phosphorylation and sulfini-
lation. In fact, PRXs appear to be the major scavengers of
signaling ROS, akin to phosphatases in the kinase-
phosphatase system, and thus constitute a crucial compo-
nent of redox signaling [7, 16, 23, 31–34]. Moreover, some
members of aquaglyceroporin and aquaporin protein
families can enhance the permeability of cell membranes
to H2O2, thus providing an additional level of regulation
to ROS-mediated signaling [16].
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Thus, the complex role of ROS in T-cell biology can
be simplified by dividing it in two parts: (i) the effects of
large exogenous quantities of ROS, known as oxidative
stress, and (ii) the function of compartmentalized, dose-
and time-controlled endogenous ROS (hereafter referred
to as signaling ROS). The latter can be implicated in
both the activation and the apoptosis of T cells. This
review covers all three aspects of ROS involvement in
T-cell functions.
Review
T cells and oxidative stress
T cells are often present in close proximity to phagocytic
cells, which are known to produce large amounts of
ROS during respiratory burst. Moreover, activated T cells
can trigger respiratory burst by direct contacts with
phagocytes [35], as well as by secreted cytokines. The
phagocyte-produced ROS can reach T cells and cause
oxidative stress (Fig. 1). For example, it has been shown
that activated neutrophils inhibit DNA synthesis in
human T cells proportionally to superoxide levels in the
medium (measured by cytochrome c reduction) [36].
More importantly, the treatment with the glutathione
precursor N-acetyl cysteine (NAC) or catalase prevents
the inhibition [36]. Further analysis showed that this
impairment of DNA synthesis is associated with alter-
ations in the T-cell receptor (TCR) signaling, including
conformational changes in TCRζ and LCK, reduced
PLCγ-1 phosphorylation and calcium flux, and increased
ERK phosphorylation [36]. Nevertheless, this study
showed that activated neutrophils do not induce apop-
tosis in T cells. Interestingly, a different study demon-
strated the decreased viability of human CD4+ T cells
upon coculture with autologous granulocytes, which was
reversed by the addition of catalase [37]. Another study
attempted to mimic the effects of phagocyte-derived
ROS by treating human T cells with polyamine oxidase-
generated H2O2 for prolonged time [38]. This treatment
suppressed the tyrosine phosphorylation, calcium flux,
NFAT and NFkB (but not AP-1) activation, and IL-2 pro-
duction [38]. Thus, it can be concluded from these studies

















Fig. 1 The redox regulation of T-cell state. Activated phagocytes produce H2O2 via NOX-2. H2O2 either oxidizes thiols (SH-) on the surface
of T cells or enters inside T cells. Intracellularly, H2O2 either oxidizes glutathione (GSH) or interferes with DNA synthesis. Activated phagocytes and den-
dritic cells (DC) secrete cysteine (Cys) to the extracellular space. Cys is taken up by T cells and converted to GSH. GSH keeps surface thiols in the
reduced state, neutralizes intracellular H2O2, and enables DNA synthesis. TCR-peptide-MHC interaction leads to the secretion of thioredoxin (TRX) by T
cells, DCs, and Tregs. TRX helps to keep surface thiols in the reduced state. Black solid arrow indicates production, black dashed arrows indicate
import/export, green solid arrows indicate activation, red bar-headed lines indicate inhibition.
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negatively affect T-cell signaling, activation, proliferation,
and, potentially, viability. Whether this mechanism has
evolved in order to prevent excessive inflammation at
sites of infection is not currently known. Interestingly,
to our knowledge, the direct suppression of T-cell
responses by macrophage-derived ROS has not been
shown yet.
To assess the impact of oxidative stress on T-cell
viability, applications of micromolar doses of H2O2 have
been performed. It appears that the susceptibility of
human T cells to H2O2-induced apoptosis strongly de-
pends on the T-cell subset. In fact, 5 μM H2O2 induces
apoptosis in CD45RO+ Tmem but not in CD45RA
+ Tnai
cells, via the mitochondrial depolarization and caspase
activation [39]. Similarly, CD4+ CD45RA+ Tnai cells are
less likely to undergo cell death upon incubation with
5–20 μM H2O2 than CD4
+ CD45RA− Tmem cells [37]. In
contrast to conventional T cells, Treg cells have lower
intracellular ROS levels and are protected from H2O2-
induced death [37]. Moreover, 10 μM H2O2 does not
affect Treg suppressive capacity [37]. Interestingly,
100 μM H2O2 completely eliminates CD4
+ T cells but
has no effect on CD4+ T-cell blasts [40]. Thus, T-cell re-
sistance to exogenous H2O2decreases in the following
order: Teff > Treg > Tnai > Tmem, which may reflect the
probability of a given subset to appear near ROS-
producing phagocytes in an inflamed environment. It is
likely that Teff cells are largely protected from ROS-
mediated death and can assist phagocytes in the elimin-
ation of pathogens. However, it is unclear whether the
application of a single H2O2 dose, as compared to the
continuous production of ROS by phagocytes, has a
physiologically meaningful effect on T cells.
Phagocytic cells regulate the redox state of the micro-
environment not only by releasing ROS but also by
producing antioxidants, especially the glutathione pre-
cursor cysteine (Fig. 1). In fact, activated murine macro-
phages secrete cysteine that can be taken up by T cells,
resulting in the increased intracellular glutathione level
[41]. Dendritic cells (DCs) also can secrete cysteine
(Fig. 1). The LPS stimulation or the coincubation of
murine DCs with T cells leads to the release of cysteine
by DCs, its subsequent uptake by T cells, and conversion
to glutathione [42]. This correlates with the acquisition
of the reduced state by the T-cell surface thiols [42].
Human DCs also secrete cysteine, as well as thiol-
reducing TRX, upon co-incubation with alloreactive T
cells [43]. The coculture of antigen-pulsed human DCs
with autologous T cells leads to increase in the levels of
cell-surface and intracellular thiols in antigen-specific T
cells and protects them from H2O2-induced apoptosis
[44]. Thus, activated macrophages and DCs secrete
cysteine to the extracellular space, which is taken up by
T cells and converted to the antioxidant glutathione.
Glutathione helps to counteract the suppressive effects
of phagocyte-derived ROS. The interesting question is
whether also neutrophils can release cysteine or TRX
upon activation, and if not, whether this contributes to
the suppressive effects of their respiratory burst on T-cells
[36, 37]. It could be possible that neutrophils do not
release antioxidants to maximize their antimicrobial
killing capacity, during the acute phase of inflammation,
whereas macrophages and DCs release cysteine to protect
T-cells from ROS during antigen presentation, in late and
chronic inflammation.
Interestingly, murine Tregs can suppress cysteine
release by DCs, leading to the oxidation of surface thiols,
decrease in intracellular glutathione, and reduction in
DNA synthesis in conventional T cells [42]. The addition
of exogenous cysteine partially reverts the Treg-induced
inhibition of DNA synthesis in murine T cells [45].
Further experiments showed that murine Tregs suppress
glutathione synthesis and cysteine release by DCs in a
CTLA-4-dependent manner [45] (Fig. 1). Thus, Tregs can
interfere with the cysteine release by DCs and hence
allow phagocyte-derived ROS to inhibit T-cell activation.
It is crucial to confirm this previously unknown mech-
anism of suppression in human Tregs. Interestingly, in
contrast to conventional T cells, human Tregs have
higher thiol content (but express similar levels of cata-
lase, manganese SOD (MnSOD, SOD-2) and copper-zinc
SOD (CuZnSOD, SOD-1)) and are more resistant to cell
death induced by granulocyte-secreted H2O2 [37]. More-
over, human Tregs express and secrete more TRX-1 than
conventional T cells and upregulate it stronger upon
stimulation [46] (Fig. 1). Their ability to suppress T cells
by contributing to the formation of an oxidative milieu
is thus questionable.
Glutathione is required for DNA synthesis in murine
[42, 45, 47] and human [48, 49] T cells, as well as for
proper LAT conformation in human T cells [50]. It
seems that particular levels of this antioxidant are
required to maintain redox balance in T cells, which, in
turn, appears to be indispensable for signaling and
proliferation. However, it cannot be excluded that T-cell
proliferation depends on some redox-unrelated func-
tions of glutathione. Further investigation is required to
distinguish between those possibilities.
Overall, under physiological conditions, there is likely
an equilibrium between ROS and antioxidant systems,
which is required for the proper functioning of T cells
(Fig. 1). However, the perturbation of this equilibrium
by changing the levels of ROS or antioxidants can
result in T-cell hyper- or hyporesponsiveness, which, in
turn, may lead to the development of various patholo-
gies. For example, a genetic deficiency in ROS produc-
tion by macrophages [51] or artificially increased thiol
levels in T cells [52] lead to T cell-mediated arthritis
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upon the collagen immunization of mice. On the con-
trary, myeloid-derived suppressor cells, found in the
majority of cancer patients, inhibit T cells by lowering
the amount of cysteine released by macrophages and
DCs, at least in mice [53].
ROS as regulators of activation-induced cell death
The stimulation of previously activated T cells – also
called T-cell blasts – results in activation-induced cell
death (AICD) [54], a process which is accompanied by the
release of ROS. NOX-2, the major ROS-producing en-
zyme of phagocytes, has been shown to be expressed also
in T-cell blasts, albeit at a very low level [55]. The same
study showed that the TCR stimulation of murine T-cell
blasts induces the Fas-dependent oxidation of the ROS-
sensitive dye 2 ’,7 ’-dichlorofluorescein diacetate (DCFDA)
by NOX-2-derived ROS [55] (Fig. 2). Moreover, this
stimulation also induces transient DCFDA oxidation that
is not dependent on Fas or NOX-2, as well as the Fas-
dependent oxidation of the superoxide-sensitive dye dihy-
droethidium (DHE) that is not mediated by NOX-2 [55],
indicating that at least two more sources of ROS are in-
volved in AICD. Similarly, in human T-cell blasts, TCR
stimulation triggers the MEK-dependent oxidation of
DHE and DCFDA [56, 57]. Moreover, TCR-triggered
DCFDA oxidation in human CD4+ T-cell blasts is
dependent on the DUOX-1 [58]. Other group has shown
that the TCR stimulation of human T-cell blasts leads to
DHE and DCFDA oxidation, FasL expression, and cell
death that all depend on mitochondrial Complex I [59–
61]. Thus, the ligation of TCR or Fas in T-cell blasts can
lead to ROS production via NOX-2, DUOX-1, mitochon-
dria, and possibly other sources (Fig. 2). However, it re-
mains to be shown whether human T-cell blasts produce
ROS via NOX-2, and whether murine blasts produce ROS
via DUOX-1 or mitochondria, upon TCR triggering.
To understand the function of the different sources of
ROS in T-cell blasts, RNA interference and knockout
mice have been used. It has been shown that MEK and
ERK activation is enhanced, whereas AKT activation is
suppressed, in T-cell blasts from NOX-2-deficient mice






















Fig. 2 ROS in activation-induced T-cell death. TCR triggering leads to the activation of DUOX-1, which produces H2O2 that enhances
the activation of ZAP-70 and the formation of the SHP-2-GAB-2-GRB-2-PLCγ-1 complex. MEK-ERK pathway increases O2
•- production by
mitochondrial Complex I (CI), which leads to the expression of FasL. Superoxide dismutase (SOD), vitamin E (VitE), and glutathione (GSH) interfere with
FasL expression. FasL triggers Fas that initiates apoptosis execution, further enhances O2
•- production by CI, and activates NOX-2. NOX-2 produces H2O2
that enters the cell and activates AKT but inhibits MEK. H2O2 is neutralized by peroxiredoxin (PRX) and GSH. Black solid arrows indicate production,
black dashed arrow indicates import, green solid arrows indicate activation, red bar-headed lines indicate inhibition. Skull and bones indicate apoptosis
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human CD4+ T-cell blasts leads to decrease in the ZAP-
70, PLCγ-1, and ERK phosphorylation, as well as PLCγ-
1, SHP-2, and GAB-2 association with GRB-2 [58]
(Fig. 2). Thus, NOX-2 and DUOX-1-derived ROS are
involved in TCR-mediated signaling in T-cell blasts, but
their effects are different. This might be due to the
different localization of NOX-2 and DUOX-1 in T cells
and/or the different timing of their activation. Unfortu-
nately, it is not possible to study the function of ROS
from mitochondria by performing the knockdown of
Complex I, as this will lead to the general impairment of
mitochondrial function and will affect cell metabolism.
Various antioxidant compounds and the overexpres-
sion of antioxidant enzymes have also been used in
order to understand the function of ROS in the signaling
and the apoptosis of T-cell blasts (Fig. 2). In agreement
with the results from NOX-2-deficient mice [55], both
the addition of NAC and the overexpression of PRX-2
sustain MEK and ERK phosphorylation but delay AKT
phosphorylation in human T-cell blasts [57]. This
indicates that intracellular H2O2 is the main mediator of
the observed NOX-2 effects in T-cell blasts. The overex-
pression of CuZnSOD or MnSOD (but not catalase or
TRX peroxidase) in human T-cell blasts abrogates FasL
expression [56], strengthening the evidence for mitochon-
drial O2
•- participation in this process [59–61]. Addition-
ally, FasL upregulation and the cell death of human T-cell
blasts are prevented by NAC [59, 61] and vitamin E [62].
In summary, it seems that several different sources of
ROS are involved in the AICD of T cells (Fig. 2). First,
H2O2 produced by DUOX-1 upon TCR triggering serves
to amplify proximal signaling events downstream of the
TCR. Next, O2
•- released from mitochondrial Complex I,
potentially in response to ERK signaling, triggers the
expression of FasL. Finally, Fas ligation activates NOX-2,
which probably assists the execution of the apoptotic
program via the H2O2-mediated activation of AKT and
the inhibition of MEK. Moreover, cell-intrinsic antioxi-
dants, such as glutathione, vitamin E, MnSOD, and
CuZnSOD, interfere with FasL expression, thus counter-
acting AICD. A better understanding of the role of ROS
in the mechanisms of AICD could help in the develop-
ment of therapeutic strategies for diseases in which T
cells either die excessively or are not properly cleared
during the contraction phase of immune response, such
as AIDS or autoimmune diseases, respectively. As an
example, vitamin E has already been shown to reduce
FasL expression and AICD in T cells from HIV-infected
patients [62].
ROS as regulators of the activation of primary T cells
There is evidence that primary human and murine T
cells produce ROS upon stimulation with different
agents. However, it cannot be excluded that the detected
ROS originate from contaminating phagocytic cells,
which are almost inevitably present in any preparation
of primary T cells. Phagocytes can be activated by
various agents used to stimulate T cells, for example by
PMA or by anti-TCR antibodies via Fc receptors [63].
Desirably, the purity of the T-cell preparation should be
very high (>99 %), and an isotype-matched control
antibody should be used to discriminate between the T
cell-derived ROS and the ROS of phagocytic origin.
Unfortunately, these conditions have been rarely met.
Moreover, activated T cells can induce respiratory burst
in phagocytes by direct contacts [35], so the use of an
isotype control is not the ultimate solution to this prob-
lem. Thus, the detection of specific T cell-derived ROS is
a challenging task. The following paragraph summarizes
data showing ROS production in primary human and
murine T cells (Fig. 3).
TCR or CD28 stimulation of human T cells induces
5-lipoxygenase-dependent DCFDA oxidation and de-
creases intracellular glutathione levels [64]. TCRxCD28
stimulation of human or murine T cells induces extracel-
lular O2
•- production, measured using the luminol-based
Diogenes system. O2
•- production is completely abrogated
in T-cell preparations from NOX-2-deficient mice [65].
Similarly, TCR stimulation of murine CD4+ T cells induces
NOX-2-dependent DCFDA oxidation [66]. Thus, these
data indicate that NOX-2 is an important source of ROS
in T cells. Additionally, TCR or TCRxCD28 (but not
CD28) stimulation of murine CD4+ T cells induces the
oxidation of the mitochondrial reduction-oxidation sensi-
tive green fluorescent protein (mito-roGFP). Interestingly,
it has been shown that the oxidation of mito-roGFP is
dependent on mitochondrial calcium uptake [67]. The
same study showed that TCRxCD28 stimulation induces
the oxidation of the mitochondria-targeted superoxide-
sensitive dye MitoSOX. This oxidation is dependent on
the mitochondrial Rieske iron-sulfur protein (RISP), a
subunit of Complex III [67]. CD8+ murine T cells also
induce DCFDA oxidation upon TCR or CD28 stimulation
[68]. Collectively, the data reported above suggest that the
triggering of the TCR and CD28 in primary T cells leads
to ROS production by 5-lipoxygenase, NOX-2, and mito-
chondria. As the majority of the studies have been in per-
formed in murine T cells, their findings have to be
confirmed in human cells. However, to ultimately solve the
problem of the ROS origin, T cell-specific knockouts of
NOX-2 or other ROS-producing enzymes have to be used.
T cells from mice lacking components of NOX-2, such
as gp91phox or p47phox, could serve as a good model to
study the function of NOX-2-derived ROS in T-cell
activation. Nevertheless, results obtained using this
model should be interpreted with caution, as phagocytes
from these mice also lack functional NOX-2, and this
may indirectly affect T cells. A T-cell specific knockout
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of NOX-2 will be helpful. T cells from p47phox−/− mice
have the diminished expression of T-bet, STAT-1, and
STAT-4 transcription factors and the lowered produc-
tion of IL-2, IL-4, IFNγ, TNFα, and GM-CSF [66].
Additionally, these cells have the enhanced phosphoryl-
ation of STAT-3 and the increased production of IL-10,
IL-17, and TGFβ [66]. Overall, the p47phox deficiency
leads to differentiation towards the Th17 lineage. Inter-
estingly, another study showed that CD4+ T cells from
gp91phox−/− mice display the Th1 phenotype. These cells
produce less IL-4 and IL-5 but more IL-17 and IFNγ
than the wild-type counterparts [69]. Moreover, they
have reduced GATA-3 expression and diminished
STAT-5 and STAT-6 phosphorylation but increased T-
bet expression [69]. The stark differences in T-bet and
IFNγ expression between the two studies might be
explained by the different NOX-2 subunits that have
been knocked out, probably indicating that in addition
to participating in the assembly of PHOX they may have
other functions. However, both studies detected de-
creased IL-4 and increased IL-17 production in NOX-2-
deficient cells, indicating conversion from the Th2 to the
Th17 phenotype (Fig. 3). Interestingly, gp91
phox−/− T cells
have no defect in CD25 expression or IL-2 production
[69]. This was confirmed by a recent study, which
showed that T cells from gp91phox−/− mice have the
normal expression of CD25 and CD69 and normal
proliferation [65]. Thus, NOX-2 is required for proper
differentiation but not for the activation of primary mur-
ine T cells. The confirmation of these findings in human
T cells using shRNA or CRISPR would be helpful to
















Fig. 3 ROS in the activation of primary T cells. The ligation of CD28 leads to the activation of the lipoxygenase pathway (LOX). This enhances
the expression of CD25, IL-2, and IL-4. The triggering of TCR leads to increase in O2
•- production by mitochondrial Complex III (CIII). Whether this
O2
•- has any function is not clear. Additionally, the ligation of TCR leads to the activation of NOX-2, which produces H2O2 that enters the cell. Inside
the cell, H2O2 activates GATA-3 and STAT-6 but inhibits STAT-3. GATA-3 and STAT-6 direct T-cell differentiation towards the Th2 phenotype and
the production of IL-4 and IL-5. STAT-3 leads to differentiation into Th17 cells and to IL-17 production. Black solid arrows indicate production,
black dashed arrow indicates import, green solid arrows indicate activation, red bar-headed line indicates inhibition
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this is complicated by the low transfectability of primary
T cells [70], and by oxidative stress [71] and general acti-
vation [72] that will be induced upon electroporation.
The elucidation of the role of lipoxygenase- or RISP-
derived ROS by the downregulation of these proteins is
even more problematic, as this will additionally disturb
cell metabolism.
Another approach that has been used to understand
the functional importance of ROS in the activation of
primary T cells is incubation with antioxidants. In
murine T cells, butylated hydroxyanisole (BHA) blocks
DNA synthesis and CD25 expression [73], whereas the
mitochondria-targeted vitamin E (Mitovitamin E) abro-
gates IL-2 production [67]. In human T cells, nordihy-
droguaiaretic acid (NDGA) inhibits IL-2 synthesis [74],
whereas vitamin E suppresses IL-4 production [75].
Interestingly, catalase, superoxide dismutase, and ascor-
bate do not affect the expression of CD25 and CD69,
proliferation, and cytokine production in human T cells
[65]. It seems that antioxidants that inhibit lipid peroxi-
dation and/or lipoxygenase activity (such as NDGA,
BHA, Vitamin E, or Mitovitamin E), but not antioxi-
dants that scavenge water-soluble ROS (such as catalase,
superoxide dismutase, or ascorbate) can interfere with
the activation of primary T cells (Fig. 3). The intriguing
possibility is that reduction in the synthesis of leukotri-
enes (proinflammatory molecules downstream of lipoxy-
genase), rather than reduction in ROS levels per se [76],
could be the reason for the impairment of T-cell activa-
tion by lipid-soluble antioxidants. This hypothesis is in
agreement with the findings that NOX-2 deficient T cells
have normal CD25 and CD69 expression, IL-2 produc-
tion, and proliferation [65, 69].
Collectively, it seems that ROS produced by NOX-2
are involved in the differentiation of T cells but not in
the initial phase of T-cell activation. The further expan-
sion of knowledge on the role of NOX-2 and other ROS
sources in primary T-cells will result in the clinical
applications. For example, it has been recently shown
that T cells from patients with systemic sclerosis express
elevated levels of NOX-2 and have higher basal ROS
levels [77].
Conclusions and perspectives
T cells are not isolated entities and are present in various
tissue microenvironments. It has become evident that
the surrounding cells create a particular redox milieu
that may, in turn, influence T-cell responses. For ex-
ample, neutrophils in the inflamed tissues produce large
amounts of ROS, which can suppress or even kill T cells.
On the contrary, macrophages and dendritic cells secrete
the glutathione precursor cysteine and the thiol-
reducing enzyme thioredoxin, which increase the oxida-
tion resistance of T cells. Moreover, Tregs can interfere
with these processes and hence regulate T-cell activation.
Additionally, appropriate intracellular ROS levels in T
cells are created by the controlled production of ROS via
NOX-2, DUOX-1, and mitochondria and the expression
of a variety of antioxidant systems, including superoxide
dismutases, peroxiredoxins, and glutaredoxins. Indeed,
the available data suggest that ROS play crucial roles in
T-cell biology. First, ROS participate in activation-
induced cell death and hence in the termination of the
immune response. Several different sources of ROS
appear to be involved in this process. It seems that
DUOX-1 produces H2O2 that amplifies proximal TCR
signaling, mitochondrial Complex I releases O2
•- that
triggers the expression of FasL, and NOX-2 generates
H2O2 that assists the execution of the apoptotic
program. Second, ROS appear to be involved in the
differentiation of T cells but dispensable for T-cell
activation or proliferation. NOX-2-derived ROS direct
the differentiation of T cells from the Th17 to the Th2
phenotype, at least in mice. Overall, under physiological
conditions, there is an equilibrium between ROS and
antioxidants, both in the tissue microenvironment and
intracellular compartments, thus allowing normal T-cell
responses. However, this delicate balance is disturbed in
several diseases, such as systemic sclerosis, rheumatoid
arthritis, AIDS, and cancer. The better understanding of
the spatiotemporal dynamics and regulation of ROS
production and elimination in T cells and their micro-
environment is essential for the development of more
effective treatments against various immune-mediated
diseases.
Despite the remarkable progress in recent years, still
much remains to be discovered about the function of
ROS in T-cell biology. New experimental techniques
should foster considerable advances in several areas of
research. To address the compartmentalized nature of
signaling ROS, methods for the highly sensitive spatial
real-time measurement of ROS levels in living cells are
desirable. The most promising approach in this field
appears to be the combination of novel photostable,
specific, reversible ROS probes [78] with the high-
resolution microscopy of living cells [79]. The imaging
flow cytometry [80], which combines the high through-
put and populational analysis capabilities of traditional
flow cytometry with the spatial resolution of micros-
copy, may also become particularly helpful. In order to
discriminate between ROS produced by T cells and
phagocytes, T-cell specific knockout mice for NOX-2,
DUOX-1, and other ROS-producing enzymes are indis-
pensable. Methods to efficiently and stably downregulate
these proteins in primary human T cells without inducing
oxidative stress, cell death, and cell preactivation are also
essential. The microfluidic [81] delivery of shRNAs or
CRISPRs [82] is amongst the most promising approaches.
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The same technique may be applied to knockdown
peroxiredoxins, the major counterbalance to NOX en-
zymes. To understand the role of mitochondrial ROS,
the organelle-targeted antioxidants [83] seem to be
almost the exclusive tool, as it is not possible to inhibit
the mitochondrial ROS-producing electron transport
chain without affecting mitochondrial ATP production,
calcium uptake, and metabolic functions. Finally, only
few molecular targets of ROS in T cells are currently
known [68]. The development of simple and reliable
methods to measure protein sulfenylation [84], includ-
ing the probes for real-time microscopy [85], would
allow to investigate this new exciting area of research.
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